Vir Biotechnology, Inc. VIR Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s common stock, shares authorized (in shares)?
- Vir Biotechnology, Inc. (VIR) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
- How has Vir Biotechnology, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Vir Biotechnology, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
- What is the long-term trend for Vir Biotechnology, Inc.'s common stock, shares authorized (in shares)?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.